Skip to main content
Terug
Watch Compare

Carisma Therapeutics Inc.

Datakwaliteit: 100%
CARM
OTC Manufacturing Chemicals
€ 0,03
▲ € 0,00 (9,68%)
Marktkapitalisatie: 1,34 M
Prijs
€ 0,03
Marktkapitalisatie
1,34 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Net margin of 15,29% shows strong profitability
Negative free cash flow of -22,42 M
P/E of 0,17 — trading at a low valuation
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)31,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin15,29%
Op. Margin20,62%

Veiligheid

Debt / Equity
N/A
Current Ratio0,86
Interest CoverageN/A

Waardering

PE (TTM)
0,17
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDA-0,12
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E 0,2 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % 15,3 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 3 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q22025 -€ 0,09 -€ 0,13 -43,8%
Q12025 -€ 0,12 -€ 0,22 -83,3%
Q42024 -€ 0,16 -€ 0,42 -158,5%

ETFs Holding This Stock

IRGSX IRGSX
0,38% weight
IRGIX IRGIX
0,38% weight
AVRE logo AVRE Avantis Real Estate ETF
0,17% weight
VGSR logo VGSR Vert Global Sustainable Real Estate ETF
0,13% weight
HAUZ logo HAUZ Xtrackers International Real Estate ETF
0,11% weight
WMRIX WMRIX
0,03% weight
WMMRX WMMRX
0,03% weight
DBEZ logo DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF
0,02% weight
GTPE logo GTPE Goldman Sachs MSCI World Private Equity Return Tracker ETF
0,01% weight
NARCX NARCX
0,01% weight

Dividend History

1 yr streak
Ex-Date Payment Date Amount Yield
Mar 08, 2023 — € 0,36 N/A

All Fundamental Metrics
Growth
Revenue Growth (1Y) 31,54% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 52,60 M Net Income (TTM) 8,04 M
ROE N/A ROA 139,06%
Gross Margin N/A Operating Margin 20,62%
Net Margin 15,29% Free Cash Flow (TTM) -22,42 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,86
Interest Coverage N/A Asset Turnover 9,10
Working Capital -942.000 Tangible Book Value -867.000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs
Valuation
P/E Ratio 0,17 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,03
PEG Ratio N/A Forward PEG N/A
EV/EBITDA -0,12 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1673,96%
Market Cap 1,34 M Enterprise Value -1,44 M
Per Share
EPS (Diluted TTM) 0,19 Revenue / Share 1,26
FCF / Share -0,54 OCF / Share -0,54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion -278,72%
SBC-Adj. FCF -24,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 19,60 M 14,90 M — — —
Net Income -60,48 M -86,88 M -19,88 M -336.000,0 -22,40 M
EPS (Diluted) -1,46 -2,59 -0,10 0,00 —
Gross Profit — — — — —
Operating Income -62,18 M -88,73 M -25,91 M -8,55 M -21,08 M
EBITDA — — — — —
R&D Expenses 59,67 M 74,13 M 38,59 M 25,31 M 29,19 M
SG&A Expenses — — — — —
D&A 3,35 M 2,84 M 13.000,0 85.000,0 122.000,0
Interest Expense — — — — —
Income Tax — — -3,88 M -8,27 M 1,45 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 30,46 M 89,55 M 189,17 M 240,75 M 122,82 M
Total Liabilities 58,37 M 63,02 M 30,98 M 69,04 M 132,05 M
Shareholders' Equity -27,91 M 26,53 M 158,19 M 171,71 M -9,23 M
Total Debt — — — — —
Cash & Equivalents 17,91 M 77,61 M 112,55 M 162,64 M 52,39 M
Current Assets 23,83 M 80,47 M 189,14 M 205,61 M 62,87 M
Current Liabilities 16,06 M 15,91 M 30,98 M 11,57 M 18,05 M